phosphatidylcholines has been researched along with endomorphin 1 in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (endomorphin 1) | Trials (endomorphin 1) | Recent Studies (post-2010) (endomorphin 1) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 448 | 2 | 109 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | endomorphin 1 (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.026 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0275 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0363 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchfield, JT; Koda, Y; Liang, MT; Toth, I | 1 |
1 other study(ies) available for phosphatidylcholines and endomorphin 1
| Article | Year |
|---|---|
In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue.
Topics: Analgesics, Opioid; Biological Availability; Caco-2 Cells; Drug Delivery Systems; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Oligopeptides; Permeability; Phosphatidylcholines; Solubility | 2008 |